Stockscreener 앱 받기
1.00
3.89%
0.0374
전일 마감가:
$0.9626
열려 있는:
$0.95
하루 거래량:
245.59K
Relative Volume:
0.55
시가총액:
$32.06M
수익:
-
순이익/손실:
$-42.37M
주가수익비율:
-0.9358
EPS:
-1.0686
순현금흐름:
$-34.94M
1주 성능:
+2.04%
1개월 성능:
-15.97%
6개월 성능:
-72.90%
1년 성능:
-62.96%
1일 변동 폭
$0.9401
$1.04
1주일 범위
$0.935
$1.10
52주 변동 폭
$0.6844
$5.75
Skye Bioscience Inc Stock (SKYE) Company Profile
명칭
Skye Bioscience Inc
전화
(858) 410-0266
주소
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
SKYE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SKYE
Skye Bioscience Inc.
|
3.10 | 12.89M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
3.01 | 4.25B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.93 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.86 | 370.02M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
8.28 | 332.44M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.64 | 0 | 0 | 0 | 0 | 0.00 |
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2025-08-15 | 개시 | Evercore ISI | Outperform |
| 2025-02-28 | 개시 | William Blair | Outperform |
| 2024-09-30 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-10 | 개시 | JMP Securities | Mkt Outperform |
| 2024-07-09 | 개시 | Craig Hallum | Buy |
| 2024-05-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-04-12 | 개시 | Oppenheimer | Outperform |
모두보기
Skye Bioscience Inc 주식(SKYE)의 최신 뉴스
Skye Bioscience, Inc. Class Action Reminder: Lead Plaintiff Deadline January 16, 2026 - Intellectia AI
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit - PR Newswire
Skye Bioscience, Inc. (NASDAQ: SKYE) Investor NOTICE: Deadline in Lawsuit on January 16, 2026 - openPR.com
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Skye Bioscience, Inc.(SKYE) Shareholders - GlobeNewswire Inc.
SKYE DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Skye - GlobeNewswire
JYD DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important January 20 Deadline in Securities Class Action - GlobeNewswire Inc.
SKYE BIOSCIENCE FINAL DEADLINE ALERT: Bragar Eagel & - GlobeNewswire
Press Telegram - FinancialContent
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - FinancialContent
Class Action Filed Against Skye Bioscience, Inc. (SKYE)January 16, 2026 Deadline to JoinContact The Gross Law Firm - PR Newswire
Cantor Fitzgerald maintains Neutral rating on Skye Bioscience stock By Investing.com - Investing.com UK
Shareholders that lost money on Skye Bioscience, Inc. - GlobeNewswire
Skye Bioscience Faces Class Action for Securities Fraud; Investors Can Join by Jan 16, 2026 - Intellectia AI
Portnoy Law Firm Announces Class Action on Behalf of Skye Bioscience, Inc. Investors - GlobeNewswire
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Chartmill
Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the - GuruFocus
FRIDAY DEADLINE: Berger Montague Advises Skye Bioscience, Inc. (NASDAQ: SKYE) Investors to Inquire About a Securities Fraud Class Action by January 16, 2026 - PR Newswire
Skye Bioscience to report CBeyond extension data in Q1, plans Phase 2b trial - Investing.com Nigeria
Skye Provides 2026 Corporate Outlook - The Globe and Mail
About Us - FinancialContent
Skye Bioscience, Inc. (NASDAQ: SKYE) Securities Class Action: Johnson Fistel Reminds Investors of January 16 Deadline to Seek Lead Plaintiff Appointment - GlobeNewswire
SKYE BIOSCIENCE CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds Skye ... - Bluefield Daily Telegraph
SKYE BIOSCIENCE CLASS ACTION REMINDER: Bragar Eagel & - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Skye Bioscience, - GlobeNewswire
Skye (SKYE) Aims to Advance Nimacimab Studies in 2026 - GuruFocus
Companies Like Skye Bioscience (NASDAQ:SKYE) Could Be Quite Risky - Yahoo Finance
Published on: 2026-01-11 00:47:59 - ulpravda.ru
What margin trends mean for Skye Bioscience Inc. stockJuly 2025 Closing Moves & Stepwise Swing Trade Plans - Улправда
SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights - The AI Journal
Skye Bioscience, Inc. Class Action: Levi & Korsinsky Reminds Skye Bioscience, Inc. ... - Bluefield Daily Telegraph
Skye Bioscience, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
What Investors Can Learn from the Skye Bioscience Securities Fraud Allegations: A Risk Assessment Guide - TipRanks
Investors who lost money on Skye Bioscience, Inc.(SKYE) should c - GuruFocus
SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - FinancialContent
Franklin Credit Management CorporationSKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights - FinancialContent
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your RightsSKYE - Sahm
Is Skye Bioscience Inc. (09R) stock a safe buy pre earnings2025 Winners & Losers & AI Powered Trade Plan Recommendations - Улправда
Is Skye Bioscience Inc. stock a safe haven assetQuarterly Portfolio Report & AI Powered Trade Plan Recommendations - ulpravda.ru
Securities Lawsuit Alert: Skye Bioscience, Inc. (SKYE)Contact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
Levi & Korsinsky Notifies Skye Bioscience, Inc. (SKYE) InvestorsLead Plaintiff Deadline on January 16, 2026 - ACCESS Newswire
Levi & Korsinsky Urges Skye Bioscience, Inc. (SKYE) Shareholders to Act Before Lead Plaintiff Deadline January 16, 2026 - ACCESS Newswire
Class Action Filed Against Skye Bioscience, Inc. (SKYE) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire
Why hedge funds are buying Skye Bioscience Inc. stock2025 Investor Takeaways & AI Forecast Swing Trade Picks - ulpravda.ru
Recover Investment Losses: Class Action Initiated Against Skye Bioscience, Inc. (SKYE) - ACCESS Newswire
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pend - GuruFocus
Treasury Yields: Is Skye Bioscience Inc. (09R) stock worth holding before Fed meetingPortfolio Gains Summary & Daily Stock Trend Watchlist - ulpravda.ru
Lawsuit Alert: Investors who lost money with shares of Skye - openPR.com
Securities Lawsuit Alert: Skye Bioscience, Inc. (SKYE) InvestorsContact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
A Look At Halozyme Therapeutics (HALO) Valuation After New ENHANZE Obesity Partnership With Skye Bioscience - Yahoo Finance
Skye Bioscience Inc (SKYE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Skye Bioscience Inc 주식 (SKYE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schwab Andrew J. | Director |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 22 '25 |
Sale |
3.42 |
170,449 |
582,936 |
57,493 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
4.73%
0.92%
자본화:
|
볼륨(24시간):